173 related articles for article (PubMed ID: 29419722)
1. Detection of Drug-Exposed Newborns.
Wabuyele SL; Colby JM; McMillin GA
Ther Drug Monit; 2018 Apr; 40(2):166-185. PubMed ID: 29419722
[TBL] [Abstract][Full Text] [Related]
2. Biological matrices for the evaluation of in utero exposure to drugs of abuse.
Lozano J; García-Algar O; Vall O; de la Torre R; Scaravelli G; Pichini S
Ther Drug Monit; 2007 Dec; 29(6):711-34. PubMed ID: 18043469
[TBL] [Abstract][Full Text] [Related]
3. Effects of addictive substances during pregnancy and infancy and their analysis in biological materials.
Płotka J; Narkowicz S; Polkowska Z; Biziuk M; Namieśnik J
Rev Environ Contam Toxicol; 2014; 227():55-77. PubMed ID: 24158579
[TBL] [Abstract][Full Text] [Related]
4. Drug abuse's smallest victims: in utero drug exposure.
Huestis MA; Choo RE
Forensic Sci Int; 2002 Aug; 128(1-2):20-30. PubMed ID: 12208017
[TBL] [Abstract][Full Text] [Related]
5. Maternal and neonatal hair and breast milk in the assessment of perinatal exposure to drugs of abuse.
Joya X; Pacifici R; Salat-Batlle J; García-Algar O; Pichini S
Bioanalysis; 2015; 7(10):1273-97. PubMed ID: 26045006
[TBL] [Abstract][Full Text] [Related]
6. Bioanalysis for cocaine, opiates, methadone, and amphetamines exposure detection during pregnancy.
Concheiro M; Lendoiro E; de Castro A; Gónzalez-Colmenero E; Concheiro-Guisan A; Peñas-Silva P; Macias-Cortiña M; Cruz-Landeira A; López-Rivadulla M
Drug Test Anal; 2017 Jun; 9(6):898-904. PubMed ID: 27595432
[TBL] [Abstract][Full Text] [Related]
7. Bioanalytical procedures for monitoring in utero drug exposure.
Gray T; Huestis M
Anal Bioanal Chem; 2007 Aug; 388(7):1455-65. PubMed ID: 17370066
[TBL] [Abstract][Full Text] [Related]
8. Alternate Matrices: Meconium, Cord Tissue, Hair, and Oral Fluid.
Palmer KL; Krasowski MD
Methods Mol Biol; 2019; 1872():191-197. PubMed ID: 30350291
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Biological Screening and Diagnostic Indicators to Detect In Utero Opiate and Cocaine Exposure Among Mother-Infant Dyads.
Stabler M; Giacobbi P; Chertok I; Long L; Cottrell L; Yossuck P
Ther Drug Monit; 2017 Dec; 39(6):640-647. PubMed ID: 28937537
[TBL] [Abstract][Full Text] [Related]
10. Alternative matrices for cocaine, heroin, and methadone in utero drug exposure detection.
Concheiro M; González-Colmenero E; Lendoiro E; Concheiro-Guisán A; de Castro A; Cruz-Landeira A; López-Rivadulla M
Ther Drug Monit; 2013 Aug; 35(4):502-9. PubMed ID: 23851907
[TBL] [Abstract][Full Text] [Related]
11. Testing Unconventional Matrices to Monitor for Prenatal Exposure to Heroin, Cocaine, Amphetamines, Synthetic Cathinones, and Synthetic Opioids.
Carlier J; La Maida N; Di Trana A; Huestis MA; Pichini S; Busardò FP
Ther Drug Monit; 2020 Apr; 42(2):205-221. PubMed ID: 31809406
[TBL] [Abstract][Full Text] [Related]
12. Prenatal exposure to substance of abuse: a worldwide problem.
Narkowicz S; Płotka J; Polkowska Ż; Biziuk M; Namieśnik J
Environ Int; 2013 Apr; 54():141-63. PubMed ID: 23454110
[TBL] [Abstract][Full Text] [Related]
13. Drugs of abuse testing in meconium.
Gareri J; Klein J; Koren G
Clin Chim Acta; 2006 Apr; 366(1-2):101-11. PubMed ID: 16413011
[TBL] [Abstract][Full Text] [Related]
14. Drug testing in biological samples vs. maternal surveys for the detection of substance use during whole pregnancy.
González-Colmenero E; Concheiro-Guisán A; Lorenzo-Martínez M; Concheiro M; Lendoiro E; de-Castro-Ríos A; Cañizo-Vázquez D; Martínez-Reglero C; Fernández-Lorenzo JR
J Addict Dis; 2021; 39(2):175-182. PubMed ID: 33043834
[TBL] [Abstract][Full Text] [Related]
15. Drug testing in the neonate.
Cotten SW
Clin Lab Med; 2012 Sep; 32(3):449-66. PubMed ID: 22939302
[TBL] [Abstract][Full Text] [Related]
16. Biochemical Screening for in utero Drug Exposure.
Wright TE
Drug Metab Lett; 2015; 9(2):65-71. PubMed ID: 26411469
[TBL] [Abstract][Full Text] [Related]
17. Comparison of umbilical cord tissue and meconium for the confirmation of in utero drug exposure.
Colby JM
Clin Biochem; 2017 Sep; 50(13-14):784-790. PubMed ID: 28288850
[TBL] [Abstract][Full Text] [Related]
18. Maternal hair testing for the assessment of fetal exposure to drug of abuse during early pregnancy: Comparison with testing in placental and fetal remains.
Falcon M; Pichini S; Joya J; Pujadas M; Sanchez A; Vall O; García Algar O; Luna A; de la Torre R; Rotolo MC; Pellegrini M
Forensic Sci Int; 2012 May; 218(1-3):92-6. PubMed ID: 22036306
[TBL] [Abstract][Full Text] [Related]
19. Testing ethylglucuronide in maternal hair and nails for the assessment of fetal exposure to alcohol: comparison with meconium testing.
Morini L; Marchei E; Tarani L; Trivelli M; Rapisardi G; Elicio MR; Ramis J; Garcia-Algar O; Memo L; Pacifici R; Groppi A; Danesino P; Pichini S
Ther Drug Monit; 2013 Jun; 35(3):402-7. PubMed ID: 23666568
[TBL] [Abstract][Full Text] [Related]
20. Drug testing in support of the diagnosis of neonatal abstinence syndrome: The current situation.
Langman LJ; Rushton AM; Thomas D; Colbourne P; Seiden-Long I; Brun MM; Colantonio D; Jannetto PJ
Clin Biochem; 2023 Jan; 111():1-10. PubMed ID: 36379240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
